Anti-PD-1 - Globe Thesis

Keyword [Anti-PD-1] Result: 81 - 100 \| Page: 5 of 6
81.	Boosting Anti-PD-1 Therapy With Metformin-Loaded Macrophage-Derived Microparticles
82.	Biomimetic Sonodynamic Therapy-Nanovaccine Integration Platform Potentiates Anti-PD-1 Therapy In Hypoxic Tumors
83.	Effectively Remodeling Tumor-associated Macrophages And Killing Cancer Stem Cells By Drug-loaded Extracellular Vesicles
84.	Targeting Atherogenic T-cells As A Novel Therapeutic In Reducing Atherosclerosis In Humans
85.	Development Of A Machine Learning-based Radiomics Signature For Estimating Breast Cancer TME Phenotypes And Predicting Anti-PD-1/PD-L1 Immunotherapy Response
86.	Study On The Anti-tumor Efficacy And Mechanism Of Bruceajavanica Oil Emulsion
87.	A VEGFR Targeting Peptide-drug Conjugate Combined With Transarterial Embolization/Anti-PD-1 Antibody In The Treatment Of Hepatocellular Carcinoma
88.	Study On The Mechanism Of Acquiring Resistance To Anti-PD-1 Immunotherapy Mediated By Macrophage-derived Itaconate
89.	Investigation Of The Antitumor Effects,immunotherapeutic Mechanism And Preclinical Safety Of A Novel Oncolytic Herpes Simplex Virus Carrying Genes Encoding For Humanized Scfv Against Human PD-1
90.	Treatment Of Small-molecule Targeted Agents Combined With Immune Checkpoint Inhibitors In Advanced Solid Tumors And The Relevant Mechanisms
91.	Radiotherapy Combined Anti-PD-1 For The Patients With Unresectable Hepatocellular Carcinoma:A Clinical Research
92.	Regulation Of CD8~+T Cells Infiltration And Immunotherapy By CircMGA/HNRNPL Complex In Bladder Cancer
93.	The Mechanism Study Of M6A Demethylase ALKBH5 Regulating FGL1 Expression To Influence The Effect Of Anti-PD-1/PD-L1 Therapy In Bladder Cancer
94.	Anti-PD-1/PD-L1 Immunotherapy Response Prediction Signature Construction And Drug Resistance Mechanism Exploration In Non-small Cell Lung Cancer
95.	1.Effect And Mechanism Of RNA Binding Protein PCBP1 In Lung Adenocarcinoma Metastasis 2.Transcription Factor KLF12 Mediates Anti-PD-1 Immunotherapy By Regulating CD8~+T Cells In Tumors
96.	Role And Mechanism Of Tissue Factor In Anoikis Resistance And Immune Escape In Hepatocellular Carcinoma
97.	Screening,Identification And Anti-tumor Effects Of Anti-PD-1 And Anti-CTLA-4 Nanobodies
98.	The Role And Mechanism Of Targeting PI3K Signaling Pathway And Autophagy In The Treatment Of Bladder Cancer
99.	Thorax Radiotherapy Combined With Anti-PD-1 Increased Heart Damage Throuth Autoimmunity And Can Be Reversed By Anti-IL17
100.	Mechanism Of Immune Hepatitis Aggravated By Lewis Lung Cancer And/or Anti-PD-1 In Mice And The Interventive Effect Of Ginsenoside Rd
<<First <Prev Next> Last>> Jump to